Supplementary Figure S6 from Preclinical Activity of the B7-H3–Targeting Antibody–Drug Conjugate Vobramitamab Duocarmazine in Pediatric Solid Tumors

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Plots of event-free-survival (EFS) and relative tumor volume (RTV) changes over time for Wilms tumor models. Treatment groups: A = control, B = vobra duo: 6 mg/kg, IP, Day 0 × 1, C=SYD988: 6 mg/kg, IP, Day 0 × 1. Bold lines on RTV plots represent group median tumor volume changes.